Literature DB >> 14433516

Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination.

S A PLOTKIN, A LEBRUN, H KOPROWSKI.   

Abstract

In the course of the attenuated live poliovirus vaccination trial described in the preceding paper, an estimated 46 000 African children were given CHAT strain. Among the 3400 children followed up by home visits, none developed paralytic poliomyelitis or aspetic meningitis. When bled 2-3 months after vaccination, 60% of previously type-1 negative children had antibodies; interference by wild enteric viruses is suggested in explanation of this low figure.Two months after the beginning of vaccination, a type-1 poliomyelitis epidemic broke out, largely concentrated in a district in which no vaccination had yet been done. No geographical, chronological or family association between vaccination and poliomyelitis cases could be found. Of a total of 99 cases, 10 were in vaccinated children; but the intervals between vaccination and onset and identification of viruses from patients indicated that no case was caused by the vaccine.Previous vaccination with CHAT virus appeared to confer significant protection (60%) against the epidemic type 1 strain.

Entities:  

Keywords:  POLIOMYELITIS/immunology

Mesh:

Substances:

Year:  1960        PMID: 14433516      PMCID: PMC2555322     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  Intrafamilial and interfamilial spread of living vaccine strains of polioviruses.

Authors:  H M GELFAND; L POTASH; D R LEBLANC; J P FOX
Journal:  J Am Med Assoc       Date:  1959-08-22

2.  A simplified colorimetric test for poliomyelitis virus and antibody.

Authors:  M M LIPTON; A J STEIGMAN
Journal:  Proc Soc Exp Biol Med       Date:  1955-01

3.  A survey of poliomyelitis virus antibodies in French Morocco.

Authors:  J R PAUL; D M HORSTMANN
Journal:  Am J Trop Med Hyg       Date:  1955-05       Impact factor: 2.345

4.  Clinical trials in infants of orally administered attenuated poliomyelitis viruses.

Authors:  S A PLOTKIN; H KOPROWSKI; J STOKES
Journal:  Pediatrics       Date:  1959-06       Impact factor: 7.124

5.  Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity.

Authors:  M VOGT; R DULBECCO; H A WENNER
Journal:  Virology       Date:  1957-08       Impact factor: 3.616

6.  Poliomyelitis in Liberia; prevalence of the disease, sero-immunity resulting from subclinical infection, and indications for prophylactic vaccination.

Authors:  H M GELFAND; M J MILLER
Journal:  Am J Trop Med Hyg       Date:  1956-09       Impact factor: 2.345

7.  [Study of neutralizing antibodies of poliomyelitis among the Africans (Negroes and pygmies) of the Belgian Congo].

Authors:  G BARSKI; P LEPINE
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

8.  The incubation period of poliomyelitis.

Authors:  P E SARTWELL
Journal:  Am J Public Health Nations Health       Date:  1952-11

9.  A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt.

Authors:  J R PAUL; J L MELNICK; V H BARNETT; N GOLDBLUM
Journal:  Am J Hyg       Date:  1952-05

10.  In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells.

Authors:  Y KANDA; J L MELNICK
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

View more
  10 in total

1.  Historical aspects of the development of live virus vaccine in poliomyelitis.

Authors:  H KOPROWSKI
Journal:  Br Med J       Date:  1960-07-09

2.  Vaccination against poliomyelitis in Poland with types 1 and 3 attenuated viruses of Koprowski. 1. Virological studies of the vaccine strains and serological studies of the vaccinated population.

Authors:  F PRZESMYCKI; H DOBROWOLSKA; B MIRSKI; H WIOR; R STANCZYK; H ZALESKA
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

Review 3.  Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Konstantin M Chumakov; Neal A Halsey; Tapani Hovi; Philip D Minor; John F Modlin; Peter A Patriarca; Roland W Sutter; Peter F Wright; Steven G F Wassilak; Stephen L Cochi; Jong-Hoon Kim; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-28       Impact factor: 4.000

Review 4.  A Modern-World View of Host-Microbiota-Pathogen Interactions.

Authors:  Chin Yee Tan; Zeni E Ramirez; Neeraj K Surana
Journal:  J Immunol       Date:  2021-10-01       Impact factor: 5.422

5.  Antibodies against poliomyelitis and measles viruses in immunized and unimmunized children, Ghana 1976-78.

Authors:  M Böttiger; S Litvinov; F Assaad; H Lundbeck; L Heller; E G Beausoleil
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

6.  Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo. 3. Safety and efficacy during the first 21 months of study.

Authors:  S A PLOTKIN; A LEBRUN; G COURTOIS; H KOPROWSKI
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

Review 7.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 8.  Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis.

Authors:  Edward P K Parker; Beate Kampmann; Gagandeep Kang; Nicholas C Grassly
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

9.  Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.

Authors:  Mami Taniuchi; James A Platts-Mills; Sharmin Begum; Md Jashim Uddin; Shihab U Sobuz; Jie Liu; Beth D Kirkpatrick; E Ross Colgate; Marya P Carmolli; Dorothy M Dickson; Uma Nayak; Rashidul Haque; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2016-05-03       Impact factor: 3.641

Review 10.  Exploring the relationship between environmental enteric dysfunction and oral vaccine responses.

Authors:  James A Church; Edward Pk Parker; Margaret N Kosek; Gagandeep Kang; Nicholas C Grassly; Paul Kelly; Andrew J Prendergast
Journal:  Future Microbiol       Date:  2018-06-21       Impact factor: 3.165

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.